Workflow
Poly Plastic Masterbatch (SuZhou) (300905)
icon
Search documents
宝丽迪(300905) - 宝丽迪关联方占用资金表
2025-04-15 09:16
非经营性资金占用及其他关联资金往来情况汇总表 编制单位:苏州宝丽迪材料科技股份有限公司 单位:万元 附件: 苏州宝丽迪材料科技股份有限公司 2024 年度 法定代表人:_________ 主管会计工作负责人:________ 会计机构负责人(会计主管人员):_______ 汇总表第 1 页 | 非经营性资金占用 | 资金占用方名称 | | 占用方与上市公 | 上市公司核算的 | 2024 年期初占用 | 年度占用累 2024 | 年度占用 2024 | 2024 | 年度偿还累 | 2024 年期末占 | | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 司的关联关系 | 会计科目 | 资金余额 | 计发生金额(不 | 资金的利息(如 | | 计发生金额 | 用资金余额 | 占用形成原因 | | | | | | | | | 含利息) | 有) | | | | | | | 现大股东及其附属企业 | | | | | | | | | | | | | | 小计 | | - | ...
宝丽迪(300905) - 董事会对独董独立性评估的专项意见
2025-04-15 09:16
经核查公司独立董事关晋平女士、李健飞先生、陆圣江先生的任职经历以及 其签署的独立性自查文件,公司董事会认为上述人员未在公司担任除独立董事 以外的任何职务,也未在公司主要股东公司担任任何职务,与公司以及主要股 东之间不存在利害关系或其他可能妨碍其进行独立客观判断的关系,不存在影 响独立董事独立性的情况,符合《上市公司独立董事管理办法》《深圳证券交易 所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律、法规、 规范性文件及《公司章程》中关于独立董事的任职资格及独立性的相关要求。 苏州宝丽迪材料科技股份有限公司 董事会 2025年4月14日 关于独立董事独立性情况的专项意见 根据《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等要求,苏州宝丽迪材料科技股份有 限公司(以下简称"公司")董事会,于近日收到独立董事关晋平女士、李健飞 先生、陆圣江先生提交的《关于独立性的自查报告》,公司董事会就公司三位独 立董事的独立性情况进行评估,并出具如下专项意见: 苏州宝丽迪材料科技股份有限公司董事会 ...
宝丽迪(300905) - 关于召开2024年年度股东大会的通知
2025-04-15 09:15
证券代码:300905 证券简称:宝丽迪 公告编号:2025-016 4.会议召开的日期、时间: 会议召开时间:2025年5月8日(星期四)下午14:00 苏州宝丽迪材料科技股份有限公司 关于召开2024年年度股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 苏州宝丽迪材料科技股份有限公司(以下简称"公司")第三届董事会第七 次决定于2025年5月8日(星期五)召开公司2024年年度股东大会,现将本次会议 有关事项通知如下: 一、召开会议的基本情况 1.股东大会届次:2024年年度股东大会。 2.股东大会的召集人:公司董事会。 3.会议召开的合法、合规性:公司第三届董事会第七次会议审议同意召开 本次股东大会。本次股东大会的召开符合有关法律、行政法规、部门规章、规范 性文件和《公司章程》等的规定。 网络投票时间: 6.会议的股权登记日:2025 年 4 月 30 日(星期三)。 7.出席对象: (1)在股权登记日持有公司已发行有表决权股份的股东或其代理人; 截止 2025 年 4 月 30 日下午收市时在中国证券登记结算有限责任公司深圳分 公司登记 ...
宝丽迪(300905) - 监事会决议公告
2025-04-15 09:15
证券代码:300905 证券简称:宝丽迪 公告编号:2025-004 苏州宝丽迪材料科技股份有限公司 第三届监事会第六次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 苏州宝丽迪材料科技股份有限公司(以下简称"公司")第三届监事会第 六次会议于 2025 年 4 月 14 日下午 14 点以现场会议的形式召开。本次会议通知 于 2025 年 4 月 3 日以微信、电话、邮件等方式通知送达公司全体监事。公司应 出席监事 3 名,实际出席会议监事 3 名。公司董事会秘书列席了会议,会议由监 事会主席付洋女士主持。本次会议的召集、召开程序符合有关法律法规以及《公 司章程》的规定。 二、监事会会议审议情况 (一)审议通过《关于 2024 年度监事会工作报告的议案》 根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》及《公司章程》等有关规定, 公司 2024 年度监事会工作报告已编制完成。 具体内容详见公司同日披露于巨潮资讯网(www.cninfo.com.cn)的相 ...
宝丽迪(300905) - 董事会决议公告
2025-04-15 09:15
证券代码:300905 证券简称:宝丽迪 公告编号:2025-003 苏州宝丽迪材料科技股份有限公司 第三届董事会第七次会议决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 苏州宝丽迪材料科技股份有限公司(以下简称"公司")第三届董事会第 七次会议于 2025 年 4 月 14 日上午 9 点以现场会议的形式召开。本次会议通知于 2025 年 4 月 3 日以电话通知、邮件等方式送达公司全体董事。公司应出席董事 7 名,实际出席会议董事 7 名,公司全体监事、高级管理人员列席了会议,会议由 董事长徐毅明先生主持。本次会议的召集、召开程序符合有关法律法规以及《公 司章程》的规定。 二、董事会会议审议情况 与会董事经过表决,审议并通过了以下议案: (一)审议通过《关于 2024 年度董事会工作报告的议案》 经与会董事讨论,认为董事会严格按照相关法律、行政法规和中国证券监督 管理委员会的规定,认真落实和执行了股东大会的有关决议,较好地完成了公司 董事会的各项工作。该报告内容真实地反映了公司董事会 2024 年运行的实际情 况。 公司独立董事关晋平女士、李健 ...
宝丽迪(300905) - 关于公司 2024 年度利润分配预案及2025年中期分红规划的公告
2025-04-15 09:15
证券代码:300905 证券简称:宝丽迪 公告编号:2025-005 苏州宝丽迪材料科技股份有限公司 关于公司 2024 年度利润分配预案及 2025 年中期 分红规划的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 苏州宝丽迪材料科技股份有限公司(以下简称"公司")于 2025 年 4 月 14 日召开第三届董事会第七次会议及第三届监事会第六次会议,审议通过了《关于 公司 2024 年度利润分配预案及 2025 年中期分红规划的议案》。本议案尚需提交 公司 2024 年年度股东大会审议。现将具体情况公告如下: 一、利润分配预案的基本情况 1、利润分配方案的具体内容 立信会计师事务所(特殊普通合伙)审计,2024 年度公司实现归属于上市 公司股东的净利润为 114,024,811.13 元,截止 2024 年 12 月 31 日,公司合并报 表可供股东分配的利润为 304,784,852.67 元,母公司可供股东分配的利润 127,583,563.54 元。根据利润分配应以母公司的可供分配利润及合并报表的可 供分配利润孰低原则,公司 2024 年度可供股 ...
宝丽迪(300905) - 2024 Q4 - 年度财报
2025-04-15 09:05
Dividend and Financial Distribution - The company plans to distribute a cash dividend of 3 RMB per 10 shares to all shareholders, based on a total of 177,897,756 shares[3]. - The company plans to distribute a cash dividend of RMB 3 per 10 shares, totaling RMB 53,369,326.8 (including tax) based on a total share capital of 177,897,756 shares[155]. Company Structure and Governance - The company has undergone a change in its registered address, effective June 28, 2023, moving to No. 29, Xujiaguan Road, Beiqiao Street, Xiangcheng District, Suzhou[12]. - The company is listed on the Shenzhen Stock Exchange under the stock code 300905[12]. - The company has appointed Lixin Certified Public Accountants as its auditing firm for the reporting period[15]. - The company has a financial advisor, Dongwu Securities Co., Ltd., providing continuous supervision from June 5, 2023, to December 31, 2024[16]. - The company emphasizes the accuracy and completeness of its financial report, with all board members present for the meeting[3]. - The company has established a governance structure consisting of a shareholders' meeting, board of directors, and supervisory board to protect the rights of shareholders and creditors[170]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, organization, and business operations[112]. - The company has established an independent financial accounting system and does not share bank accounts with its controlling shareholders[115]. - The company has a stable management team with no significant adverse changes in its main business or senior management in recent years[119]. - The company has a clear ownership structure with no recent changes in actual control[119]. - The company has established internal management structures that operate independently from its controlling shareholders[116]. - The company has implemented a collaborative research model with universities and research institutions to foster innovation and technology transfer[45]. - The company has established a remuneration plan for directors and senior management for 2024[146]. - The company has a structured remuneration decision process involving the remuneration and assessment committee, board approval, and shareholder meeting ratification[136]. - The company has seen a diverse range of experience among its management team, with backgrounds in engineering and finance[135]. - The company has a total of 12 directors and supervisors, with varying remuneration levels based on their positions[137]. - The company has established a comprehensive performance evaluation system for senior management, ensuring transparency and compliance with legal regulations[109]. Financial Performance - The company's operating revenue for 2024 reached ¥1,363,010,300.33, representing a 13.86% increase compared to ¥1,197,056,530.15 in 2023[17]. - Net profit attributable to shareholders for 2024 was ¥114,024,811.13, up 14.61% from ¥99,487,816.04 in 2023[17]. - The net profit after deducting non-recurring gains and losses was ¥103,230,795.50, reflecting a 17.79% increase from ¥87,639,216.11 in 2023[17]. - The net cash flow from operating activities significantly improved to ¥132,734,123.46, a 162.35% increase from ¥50,594,782.70 in 2023[17]. - Basic earnings per share for 2024 were ¥0.65, a 4.84% increase from ¥0.62 in 2023[17]. - Total assets at the end of 2024 amounted to ¥2,131,594,108.81, a 5.09% increase from ¥2,028,399,085.81 at the end of 2023[17]. - The company reported a weighted average return on equity of 6.29% for 2024, slightly down from 6.40% in 2023[17]. - The gross profit margin increased to 18.30%, with gross profit amounting to ¥249,431,083.79, up by 20.91% year-on-year[54]. - The company achieved a revenue of ¥1,363,010,300.33 in 2024, representing a year-on-year growth of 13.86%[51]. - The production volume of mother pellets was 91,378 tons, with sales volume also at 91,380 tons, contributing ¥1,332,951,239.47 to revenue[55]. - The company’s overseas revenue accounted for 2.05% of total revenue, amounting to ¥27,929,940.56, with a year-on-year growth of 12.09%[51]. Research and Development - The company is focused on the production and R&D of colored masterbatches and advanced functional modified materials, aligning with the growth of the plastic processing industry in China[25][27]. - The company emphasizes R&D based on market demand and customer-specific needs, ensuring product relevance and quality[37]. - The company has developed various functional masterbatches, including energy-storing luminescent, anti-aging, and antibacterial fibers, to meet diverse customer needs[33]. - The company has established a joint laboratory for functional masterbatch with the Yangtze River Delta National Innovation Center, enhancing its research capabilities[42]. - Research and development expenses increased by 13.29% to ¥51,888,404.57, driven by enhanced investment in R&D capabilities and personnel[59]. - The company has a total of 87 patents, including 41 invention patents and 46 utility model patents, showcasing its strong focus on innovation and technology development[41]. - The company is committed to sustainable development through continuous innovation and the establishment of advanced research platforms[42]. Market Strategy and Operations - The company is focused on enhancing product coverage and market share while emphasizing eco-friendly features and special performance of products[97]. - The company aims to lower new product costs through innovative processes and applications, strengthening its core competitiveness in the market[97]. - The company is actively pursuing market expansion and optimization of production processes to meet increasing market demand[42]. - The company employs a sales model primarily focused on direct supply to end-users, supplemented by a trade model[38]. - The procurement process involves selecting suppliers based on material requirements and market conditions to ensure stable supply and quality[39]. - The company has established stable partnerships with major domestic chemical fiber manufacturers, enhancing its customer resource advantage[46]. - The company is enhancing its information technology infrastructure to improve management efficiency and operational risk prevention[99]. - The company aims to achieve dual improvements in production efficiency and product quality through smart manufacturing and automation[99]. Sustainability and Social Responsibility - The company is committed to green sustainable development by improving safety management and environmental protection measures[98]. - Environmental protection measures are in place, including certifications such as ISO14000 and ISO18000, and adherence to local regulations[174]. - The company actively participates in social responsibility initiatives, including donations and support for education[175]. - During the reporting period, the company donated 670,000 yuan to support poverty alleviation and rural revitalization efforts[175]. Financial Management and Investments - The total cash inflow from investment activities rose significantly by 525.59% to ¥935,134,802.73, indicating a strong investment strategy[63]. - The total cash and cash equivalents increased by 418.48% to ¥234,607,983.53, reflecting improved liquidity[63]. - The company has ongoing significant non-equity investments, with a total investment amount of RMB 208,168,270.35 reported[78]. - The company has not engaged in any external guarantees during the reporting period[198]. - The company has not reported any significant internal control deficiencies during the reporting period[163]. - The company has established a fundraising management system to ensure the reasonable and legal use of raised funds, improving capital efficiency[189]. Shareholder Relations and Compliance - The company strictly adheres to information disclosure requirements, ensuring timely and fair access to information for all shareholders[110]. - The company respects and protects the rights of stakeholders, balancing the interests of shareholders, employees, and society[111]. - The company will ensure compliance with the China Securities Regulatory Commission and stock exchange regulations during any share reduction activities[178]. - The company will disclose any buyback plans in accordance with relevant laws and regulations[182]. - The company commits to compensating investors for losses incurred due to false records, misleading statements, or significant omissions in the prospectus[184]. - The company will take measures to protect the interests of investors, especially small and medium-sized investors, in the event of regulatory violations[183]. Future Outlook - The company aims to become a leading international player in the liquid color masterbatch segment by 2025[95]. - The company plans to enhance its market penetration and product upgrades towards environmentally friendly and high-end solutions by 2025[95]. - Future guidance indicates a positive outlook for revenue growth, driven by strategic initiatives and market expansion efforts[125].
宝丽迪:2024年净利润1.14亿元,同比增长14.61% 拟10派3元
news flash· 2025-04-15 09:05
宝丽迪(300905)公告,2024年营业收入13.63亿元,同比增长13.86%。归属于上市公司股东的净利润 1.14亿元,同比增长14.61%。基本每股收益0.65元/股,同比增长4.84%。公司拟向全体股东每10股派发 现金红利3元(含税),送红股0股(含税),以资本公积金向全体股东每10股转增0股。 ...
宝丽迪(300905) - 东吴证券股份有限公司关于苏州宝丽迪材料科技股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易之2024年度持续督导意见暨持续督导总结报告
2025-04-15 09:04
发行股份及支付现金购买资产 并募集配套资金暨关联交易 之 2024年度持续督导意见 暨持续督导总结报告 独立财务顾问 东吴证券股份有限公司 关于 苏州宝丽迪材料科技股份有限公司 二零二五年四月 声明 东吴证券股份有限公司(以下简称"东吴证券"、"本独立财务顾问")接受 苏州宝丽迪材料科技股份有限公司(以下简称"宝丽迪"、"上市公司"或"公司") 委托,担任本次发行股份及支付现金购买资产并募集配套资金(以下简称"本次 交易")的独立财务顾问。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司重大资 产重组管理办法》《上市公司监管指引第 9 号——上市公司筹划和实施重大资产 重组的监管要求》等有关法律、法规及规范性文件的要求,按照证券行业公认的 业务标准、道德规范,本着诚实信用、勤勉尽责的精神,遵循客观、公正原则, 在认真审阅相关资料和充分了解本次交易行为的基础上,独立财务顾问出具了 《东吴证券股份有限公司关于苏州宝丽迪材料科技股份有限公司发行股份及支 付现金购买资产并募集配套资金暨关联交易之 2024 年度持续督导意见暨持续督 导总结报告》。 释义 | 在本持续督导意见中,除非另有所指,下列简称具 ...
宝丽迪(300905) - 募集资金年度存放与使用情况鉴证报告(信会师报字[2025]第ZA10924号)
2025-04-15 09:04
苏州宝丽迪材料科技股份有限公司 募集资金年度存放与使用情况 鉴证报告 2024 年度 关于苏州宝丽迪材料科技股份有限公司 2024年度募集资金存放与使用情况 专项报告的鉴证报告 信会师报字[2025]第ZA10924号 苏州宝丽迪材料科技股份有限公司全体股东: 我们接受委托,对后附的苏州宝丽迪材料科技股份有限公司(以 下简称"贵公司")2024年度募集资金存放与使用情况专项报告(以 下简称"募集资金专项报告")执行了合理保证的鉴证业务。 一、董事会的责任 贵公司董事会的责任是按照中国证券监督管理委员会《上市公司 监管指引第2号——上市公司募集资金管理和使用的监管要求(2022 年修订)》(证监会公告〔2022〕15号)、《深圳证券交易所上市公司自 律监管指引第2号——创业板上市公司规范运作》以及《深圳证券交 易所创业板上市公司自律监管指南第2号——公告格式》的相关规定 编制募集资金专项报告。这种责任包括设计、执行和维护与募集资金 专项报告编制相关的内部控制,确保募集资金专项报告真实、准确、 完整,不存在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责任是在执行鉴证工作的基础上对募集资金专项报告 ...